Kristina Melkersson

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi request reprint Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients
    Kristina Melkersson
    Sollentuna Psychiatric Polyclinic and the Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden
    J Clin Psychiatry 66:761-7. 2005
  2. ncbi request reprint Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses
    K I Melkersson
    Department of Molecular Medicine, Sollentuna Psychiatric Polyclinic, Karolinska Institute, Stockholm, Sweden
    Psychopharmacology (Berl) 170:157-66. 2003
  3. ncbi request reprint Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro
    Kristina Melkersson
    Sollentuna Psychiatric Polyclinic and Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden
    Eur Neuropsychopharmacol 14:115-9. 2004
  4. ncbi request reprint Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications
    Kristina Melkersson
    Psychiatric Polyclinic, Sollentuna Hospital, Nytorpsvägen 10 12, SE 191 35 Sollentuna, Sweden
    Drugs 64:701-23. 2004
  5. ncbi request reprint Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism
    K I Melkersson
    Sollentuna Psychiatric Polyclinic, Sollentuna Hospital, 191 35, Sollentuna, Sweden
    Psychopharmacology (Berl) 175:1-6. 2004
  6. ncbi request reprint The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro
    Kristina Melkersson
    Sollentuna Psychiatric Polyclinic, Sollentuna, Sweden
    Neuro Endocrinol Lett 26:205-8. 2005
  7. ncbi request reprint Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 32:428-36. 2011
  8. ncbi request reprint Effects of the atypical antipsychotic clozapine on insulin release in vitro
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 28:854-60. 2007
  9. ncbi request reprint Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine
    Shelley Feng
    Psychiatry Northwest, Stockholm, Sweden, Sweden
    Neuro Endocrinol Lett 33:493-8. 2012
  10. ncbi request reprint Association between body mass index and insulin receptor substrate-4 (IRS-4) gene polymorphisms in patients with schizophrenia
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 32:634-40. 2011

Detail Information

Publications15

  1. ncbi request reprint Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients
    Kristina Melkersson
    Sollentuna Psychiatric Polyclinic and the Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden
    J Clin Psychiatry 66:761-7. 2005
    ..The aim of this cross-sectional study was to investigate the degree and frequency of prolactin (PRL) elevation and related symptoms in patients treated with 3 different atypical antipsychotics: clozapine, olanzapine, and risperidone...
  2. ncbi request reprint Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses
    K I Melkersson
    Department of Molecular Medicine, Sollentuna Psychiatric Polyclinic, Karolinska Institute, Stockholm, Sweden
    Psychopharmacology (Berl) 170:157-66. 2003
    ..Recent results suggest that treatment with the atypical antipsychotics clozapine and olanzapine is associated with increased insulin and lipid levels...
  3. ncbi request reprint Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro
    Kristina Melkersson
    Sollentuna Psychiatric Polyclinic and Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden
    Eur Neuropsychopharmacol 14:115-9. 2004
    ..Interestingly, this stimulatory effect on insulin release in vitro may be supported by recent clinical findings, showing elevated insulin levels in patients being treated with clozapine or olanzapine...
  4. ncbi request reprint Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications
    Kristina Melkersson
    Psychiatric Polyclinic, Sollentuna Hospital, Nytorpsvägen 10 12, SE 191 35 Sollentuna, Sweden
    Drugs 64:701-23. 2004
    ..In this review, recommendations for prevention and treatment of the adverse metabolic effects are outlined...
  5. ncbi request reprint Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism
    K I Melkersson
    Sollentuna Psychiatric Polyclinic, Sollentuna Hospital, 191 35, Sollentuna, Sweden
    Psychopharmacology (Berl) 175:1-6. 2004
    ....
  6. ncbi request reprint The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro
    Kristina Melkersson
    Sollentuna Psychiatric Polyclinic, Sollentuna, Sweden
    Neuro Endocrinol Lett 26:205-8. 2005
    ....
  7. ncbi request reprint Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 32:428-36. 2011
    ....
  8. ncbi request reprint Effects of the atypical antipsychotic clozapine on insulin release in vitro
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 28:854-60. 2007
    ..The aim of this study was therefore to examine the influence of clozapine on insulin release in vitro...
  9. ncbi request reprint Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine
    Shelley Feng
    Psychiatry Northwest, Stockholm, Sweden, Sweden
    Neuro Endocrinol Lett 33:493-8. 2012
    ....
  10. ncbi request reprint Association between body mass index and insulin receptor substrate-4 (IRS-4) gene polymorphisms in patients with schizophrenia
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 32:634-40. 2011
    ....
  11. ncbi request reprint Evidence for a negative association between schizophrenia and a polymorphism in the insulin receptor substrate-3 (IRS-3) gene
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Neuro Endocrinol Lett 33:321-30. 2012
    ..In the present study, we chose to study the insulin receptor substrate-3 (IRS-3) gene as a candidate gene in schizophrenia...
  12. ncbi request reprint Serum creatine kinase levels in chronic psychosis patients--a comparison between atypical and conventional antipsychotics
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska Institute, c o Sollentuna Psychiatric Polyclinic, Nytorpsvägen, 10 SE 191 35 Sollentuna, Sweden
    Prog Neuropsychopharmacol Biol Psychiatry 30:1277-82. 2006
    ..In summary, the present results indicate that therapy with atypical antipsychotics like clozapine and olanzapine, in contrast to conventional agents, may be associated with serum creatine kinase elevation...
  13. ncbi request reprint Serotonin receptor 2A gene polymorphisms and schizophrenia: association with family history, diagnostic subtype and height in patients
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 30:343-51. 2009
    ..Therefore, the aim of this study was to evaluate the impact of main functionally characterized SNPs of the HTR2A gene on both the schizophrenia and clinical parameters...
  14. ncbi request reprint The insulin receptor substrate-4 (IRS-4) gene and schizophrenia: no evidence for a main genetic factor, however one report of a single schizophrenia patient with a mutation
    Kristina Melkersson
    Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Neuro Endocrinol Lett 32:52-8. 2011
    ..In this study, we therefore chose to study the insulin receptor substrate-4 (IRS-4) gene as a candidate gene in schizophrenia...
  15. ncbi request reprint Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine
    Kristina Melkersson
    Sollentuna Psychiatric Policlinic, Sollentuna Hospital, Stockholm, Sweden
    Psychosomatics 43:67-70. 2002